Panorama Capital, a Silicon Valley-based venture capital firm, has promoted Shankar Chandran and Gaurav Aggarwal to partner.
"Shankar and Gaurav have made exceptional contributions to the firm and the companies with whom they work,” says Rod Ferguson, managing director at Panorama Capital. "I am enthusiastic about them as partners who will help lead the firm into the next decade."
Chandran (pictured) and Aggarwal were previously principals with the firm and will continue to invest in startups and help entrepreneurs build companies.
Chandran leads Panorama’s efforts in the core technology sector, investing in companies developing the critical components and systems enabling the convergence of mobile technology and the web. Shankar has been a principal with the firm since its founding in 2005 and worked closely with the team since 2002 at JPMorgan Partners. He currently serves on the board of directors of Validity, CHiL Semiconductor and Neoconix.
Aggarwal invests in emerging life sciences companies and has been part of the firm as a principal since its founding. He too worked with the team while at JPMorgan Partners. He currently serves on the board of directors of Alvine Pharmaceuticals and Hyperion Therapeutics, and was previously on the board of directors at Flowcardia (acquired by Bard) and PIramed (acquired by Roche).
